Lezárult
Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria.
2024-518786-10-01· 2. fázis· Evommune Inc.· Forrás
Lezárult
Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants with Major Depressive Disorder
NCT06029439· 3. fázis· Neumora Therapeutics Inc.· Forrás
Lezárult
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
NCT06602024· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
NCT06586112· 3. fázis· Alumis Inc· Forrás
Lezárult
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
NCT06431763· 4. fázis· Novartis Pharmaceuticals· Forrás
Leállították
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata
NCT06444451· 2. fázis· Sanofi· Forrás
Lezárult
Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis
NCT05984784· 1/2. fázis· Inmagene LLC· Forrás
Lezárult
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)
2023-507721-41-00· 1. fázis· Sparrow Pharmaceuticals Inc.· Forrás
Lezárult
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
NCT06191042· 1. fázis· selectION Therapeutics GmbH· Forrás
Lezárult
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
NCT06058039· 3. fázis· Neumora Therapeutics, Inc.· Forrás
Lezárult
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
NCT06153693· 3. fázis· Mineralys Therapeutics Inc.· Forrás
Lezárult
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
NCT06108544· 3. fázis· Takeda· Forrás
Lezárult
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older
NCT06015282· 3. fázis· Seqirus· Forrás
Lezárult
The Celljuvant study, A phase 3 Immunogenicity and Safety Study of aQIVc HD Vaccine in Adults aged 50 years and older.
2023-503763-42-00· 3. fázis· Seqirus UK Limited· Forrás
Lezárult
Efficacy and Tolerability of Tasipimidine in Sleepless Patients
NCT06956495· 2. fázis· Orion Corporation, Orion Pharma· Forrás
Lezárult
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the trial around the participant, known as decentralised, and hybrid clinical trials compared to standard clinical trials that take place in hospitals or in research centres, in patients with type 2 diabetes mellitus treated with Toujeo®, a drug to help manage blood sugar levels.
2022-500449-26-00· 4. fázis· University Medical Center Utrecht· Forrás
Fut, nem toboroz
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
NCT05968430· 3. fázis· Mineralys Therapeutics Inc.· Forrás
Lezárult
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
NCT05537038· 1. fázis· BioNTech SE· Forrás
Lezárult
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971· 3. fázis· LG Chem· Forrás
Lezárult
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
NCT05566639· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
NCT05318976· 2. fázis· Inmune Bio, Inc.· Forrás
Leállították
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
NCT06281236· 1. fázis· Sparrow Pharmaceuticals· Forrás
Leállították
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
NCT04241068· 3. fázis· Biogen· Forrás
Lezárult
Long-Term PF-06651600 for the Treatment of Alopecia Areata
NCT04006457· 3. fázis· Pfizer· Forrás